Navigation Links
ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer
Date:12/8/2009

EDINA, Minn., Dec. 8 /PRNewswire/ -- ARKRAY, Inc., a global leader of human and veterinary in vitro diagnostic instruments and reagents today announced an exclusive distribution agreement with scil animal care company for the SPOTCHEM(TM) EZ Chemistry Analyzer. Scil is a global organization focused on providing high quality veterinary diagnostic equipment.

Scil's first order of business will be to re-introduce the SPOTCHEM(TM) EZ, a small bench top chemistry analyzer, to the North American veterinary industry. Other veterinary-use products from ARKRAY will follow.

More than 8,500 SPOTCHEM(TM) EZ Chemistry Analyzers have been sold globally since 2000. The SPOTCHEM(TM) EZ is a compact, bench-top analyzer that enables easy, on-the-spot testing at veterinary clinics of various sizes. The analyzer can run a panel, a single test, or a combination so veterinarians can test the way they need to without wasting unnecessary tests. The system accepts whole blood or serum samples and has a built-in centrifuge. Results are available within 8 to 15 minutes to facilitate quick diagnosis and treatment.

"We're very excited about our new partnership and look forward to launching other veterinary-use products with scil," said Jonathan Chapman, President of ARKRAY, USA.

About ARKRAY USA

ARKRAY is a global leader of high-quality, cost-effective products that are simple, convenient, and easy-to-use, including blood glucose meters, test strips, safety lancets, as well as urine and clinical chemistry products. ARKRAY invests heavily in R&D and has a strong commitment to high-quality products. For patients, this means access to cutting-edge, reliable products without sacrificing quality, and exceptional customer service.

For more information about the SPOTCHEM EZ visit www.arkraypoc.com

About scil animal care company:

Scil animal care company is a global organization dedicated to delivering animal health professionals high quality diagnostic equipment. We understand that high quality products are not enough in today's modern veterinary laboratory. Post-acquisition in-hospital training, support and service make the critical difference to the ongoing performance of the instrument as well as its financial contribution to the veterinary practice.

SOURCE ARKRAY USA


'/>"/>
SOURCE ARKRAY USA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ARKRAY, Inc. Receives FDA Clearance for New GLUCOCARD(R) Vital(TM) Blood Glucose Monitoring System
2. Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy
3. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
4. CompuCyte Announces the Release of Four-Laser Imaging Cytometers
5. Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease
6. Royalty Pharma Announces that Alexander von Perfall Joins Management Team
7. ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program
8. Hill-Rom Announces Appointment of James R. Giertz to Board of Directors
9. CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition
10. Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference
11. Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 26, 2016 One of ... has announced the formation of a new biotechnology company, Noxopharm Limited ... $6m in an IPO and to list on the ASX. ... candidate, NOX66, ready to enter a Phase 1 clinical study later ... designed to address one of the biggest problems facing cancer patients ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
Breaking Medicine Technology:
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):